Morgan Stanley’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39,442
| Closed | -$583K | – | 8100 |
|
|
2024
Q1 | $583K | Sell |
39,442
-179,634
| -82% | -$2.65M | ﹤0.01% | 5240 |
|
|
2023
Q4 | $2.94M | Buy |
219,076
+125,899
| +135% | +$1.69M | ﹤0.01% | 4730 |
|
|
2023
Q3 | $1.15M | Buy |
93,177
+10,492
| +13% | +$129K | ﹤0.01% | 4718 |
|
|
2023
Q2 | $1.02M | Buy |
82,685
+28,525
| +53% | +$351K | ﹤0.01% | 4814 |
|
|
2023
Q1 | $666K | Buy |
54,160
+44,997
| +491% | +$553K | ﹤0.01% | 5092 |
|
|
2022
Q4 | $105K | Buy |
9,163
+2,649
| +41% | +$30.4K | ﹤0.01% | 5952 |
|
|
2022
Q3 | $25K | Sell |
6,514
-844
| -11% | -$3.24K | ﹤0.01% | 6705 |
|
|
2022
Q2 | $43K | Buy |
7,358
+1,235
| +20% | +$7.22K | ﹤0.01% | 6684 |
|
|
2022
Q1 | $39K | Buy |
6,123
+1,001
| +20% | +$6.38K | ﹤0.01% | 6826 |
|
|
2021
Q4 | $19K | Sell |
5,122
-706
| -12% | -$2.62K | ﹤0.01% | 7236 |
|
|
2021
Q3 | $28K | Sell |
5,828
-5,333
| -48% | -$25.6K | ﹤0.01% | 6973 |
|
|
2021
Q2 | $72K | Buy |
11,161
+5,218
| +88% | +$33.7K | ﹤0.01% | 6501 |
|
|
2021
Q1 | $38K | Buy |
5,943
+880
| +17% | +$5.63K | ﹤0.01% | 6484 |
|
|
2020
Q4 | $34K | Buy |
5,063
+1,231
| +32% | +$8.27K | ﹤0.01% | 6282 |
|
|
2020
Q3 | $15K | Buy |
3,832
+357
| +10% | +$1.4K | ﹤0.01% | 6155 |
|
|
2020
Q2 | $12K | Sell |
3,475
-4,428
| -56% | -$15.3K | ﹤0.01% | 6131 |
|
|
2020
Q1 | $17K | Sell |
7,903
-2,863
| -27% | -$6.16K | ﹤0.01% | 5877 |
|
|
2019
Q4 | $34K | Sell |
10,766
-21,606
| -67% | -$68.2K | ﹤0.01% | 5968 |
|
|
2019
Q3 | $146K | Buy |
32,372
+23,897
| +282% | +$108K | ﹤0.01% | 5303 |
|
|
2019
Q2 | $41K | Sell |
8,475
-1,612
| -16% | -$7.8K | ﹤0.01% | 5695 |
|
|
2019
Q1 | $55K | Buy |
10,087
+186
| +2% | +$1.01K | ﹤0.01% | 5626 |
|
|
2018
Q4 | $30K | Sell |
9,901
-10,425
| -51% | -$31.6K | ﹤0.01% | 5926 |
|
|
2018
Q3 | $86K | Sell |
20,326
-62,804
| -76% | -$266K | ﹤0.01% | 5733 |
|
|
2018
Q2 | $321K | Buy |
83,130
+34,555
| +71% | +$133K | ﹤0.01% | 5346 |
|
|
2018
Q1 | $307K | Buy |
48,575
+4,916
| +11% | +$31.1K | ﹤0.01% | 5273 |
|
|
2017
Q4 | $352K | Buy |
43,659
+9,263
| +27% | +$74.7K | ﹤0.01% | 5170 |
|
|
2017
Q3 | $393K | Sell |
34,396
-43,254
| -56% | -$494K | ﹤0.01% | 5015 |
|
|
2017
Q2 | $758K | Buy |
77,650
+39,445
| +103% | +$385K | ﹤0.01% | 4567 |
|
|
2017
Q1 | $925K | Sell |
38,205
-48,680
| -56% | -$1.18M | ﹤0.01% | 4439 |
|
|
2016
Q4 | $2.79M | Sell |
86,885
-27,050
| -24% | -$868K | ﹤0.01% | 3611 |
|
|
2016
Q3 | $5.69M | Buy |
113,935
+1,633
| +1% | +$81.6K | ﹤0.01% | 2539 |
|
|
2016
Q2 | $4.76M | Buy |
112,302
+1,025
| +0.9% | +$43.5K | ﹤0.01% | 2655 |
|
|
2016
Q1 | $7.33M | Sell |
111,277
-18,107
| -14% | -$1.19M | ﹤0.01% | 2143 |
|
|
2015
Q4 | $8.04M | Buy |
129,384
+6,457
| +5% | +$401K | ﹤0.01% | 2196 |
|
|
2015
Q3 | $8.23M | Buy |
122,927
+18,888
| +18% | +$1.26M | ﹤0.01% | 2167 |
|
|
2015
Q2 | $10.1M | Buy |
104,039
+3,745
| +4% | +$364K | ﹤0.01% | 2099 |
|
|
2015
Q1 | $9.38M | Sell |
100,294
-2,832
| -3% | -$265K | ﹤0.01% | 2113 |
|
|
2014
Q4 | $9.17M | Buy |
103,126
+8,616
| +9% | +$766K | ﹤0.01% | 2151 |
|
|
2014
Q3 | $6.53M | Buy |
94,510
+30,568
| +48% | +$2.11M | ﹤0.01% | 2402 |
|
|
2014
Q2 | $3.67M | Sell |
63,942
-43,014
| -40% | -$2.47M | ﹤0.01% | 2956 |
|
|
2014
Q1 | $4.24M | Sell |
106,956
-18,905
| -15% | -$750K | ﹤0.01% | 2728 |
|
|
2013
Q4 | $5.28M | Buy |
125,861
+119,080
| +1,756% | +$4.99M | ﹤0.01% | 2513 |
|
|
2013
Q3 | $202K | Sell |
6,781
-814
| -11% | -$24.2K | ﹤0.01% | 4885 |
|
|
2013
Q2 | $403K | Buy |
+7,595
| New | +$403K | ﹤0.01% | 4413 |
|